SpotitEarly has launched its U.S. operations with $20.3 million in funding to enhance early cancer detection using AI and canine scent detection.
Amount Raised
$20.3 Million
Round Type
Funding Round
Investors
Description
SpotitEarly, a biotech firm, has entered the U.S. market with a $20.3 million funding round aimed at transforming cancer screening. Their innovative breath-based diagnostic platform combines AI with canine detection for greater accuracy. The investment will support commercialization and expansion in the U.S
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as SpotitEarly that raised within 45 days of this round, from Fundz verified event records.
- Axiles Bionics raised $7M (Series A) on June 24, 2025.
- ForSight Robotics raised $125M (Series B) on June 24, 2025.
- Shuttle Pharmaceutical Holdings raised $4.3M (Seed) on June 20, 2025.
- Lyrebird Health raised $8.9M (Funding Round) on June 18, 2025.
- Nabla raised $70M (Series C) on June 17, 2025.
- Hoppr raised $32M (Series A) on June 17, 2025.
Who to call at SpotitEarly, and when
A new round usually means SpotitEarly is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SpotitEarly raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SpotitEarly, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SpotitEarly. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SpotitEarly raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
SpotitEarly raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.